Skip to main content
Log in

Effects of fondaparinux on pulmonary embolism following hemiarthroplasty for femoral neck fracture: a retrospective observational study using the Japanese Diagnosis Procedure Combination database

  • Original Article
  • Published:
Journal of Orthopaedic Science

Abstract

Background

Pulmonary embolism (PE) is recognized as an important complication in patients undergoing hip fracture surgery. However, clinical evidence demonstrating the effectiveness of pharmacological thromboprophylaxis, including fondaparinux, is limited because the occurrence of postoperative PE after hemiarthroplasty is very low. The goal of this study was to analyze the effect of fondaparinux in reducing PE following hemiarthroplasty for femoral neck fracture using large-scale retrospective data.

Methods

Employing data from the Japanese Diagnosis Procedure Combination database from July 1 to December 31 between 2007 and 2010, we retrospectively identified 22,776 patients who underwent hemiarthroplasty for femoral neck fracture; we included those who received mechanical prophylaxis alone (n = 17,984) and those who received both mechanical prophylaxis and pharmacological prophylaxis with fondaparinux (n = 4,792). Logistic regression analysis was performed to compare the occurrence of postoperative PE with adjustment for sex, age, comorbidities, and type and duration of anesthesia.

Results

The mean age of the patients was 79.5 ± 9.4 years. Overall, postoperative PE occurred in 189 (0.83 %) patients. The rate of postoperative PE in the fondaparinux group (0.61 %) was lower than in the control group (0.89 %), although the difference was not significant in the univariate analysis (odds ratio [OR] 0.68; p = 0.055). In the multivariate analysis, the fondaparinux group showed a significantly lower rate of postoperative PE than the group receiving mechanical prophylaxis alone (OR 0.67; p = 0.047). General anesthesia and a longer duration of anesthesia were significant risk factors for postoperative PE.

Conclusions

Fondaparinux combined with mechanical prophylaxis is more effective in preventing postoperative PE following hemiarthroplasty for femoral neck fracture than mechanical prophylaxis alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sambrook P, Cooper C. Osteoporosis. Lancet. 2006;367(9527):2010–8.

    Article  CAS  PubMed  Google Scholar 

  2. Orimo H, Yaegashi Y, Onoda T, Fukushima Y, Hisoi T, Sakata K. Hip fracture incidence in Japan: estimates of new patients in 2007 and 20-year trends. Arch Osteoporos. 2009;4(1–2):71–7.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Dahl OE, Caprini JA, Colwell CW Jr, Frostick SP, Haas S, Hull RD, Laporte S, Stein PD. Fatal vascular outcomes following major orthopedic surgery. Thromb Haemost. 2005;93(5):860–6.

    CAS  PubMed  Google Scholar 

  4. Ytter YF, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwel CW Jr. Prevention of VTE in orthopaedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e278S–325S.

    Google Scholar 

  5. Powers PJ, Gent M, Jay RM, Julian DH, Turpie AG, Levine M, Hirsh J. A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. Arch Intern Med. 1989;149(4):771–4.

    Article  CAS  PubMed  Google Scholar 

  6. Jørgensen PS, Knudsen JB, Broeng L, Josephsen L, Bjerregaard P, Hagen K, Jørgensen PK, Tørholm C. The thromboprophylactic effect of a low-molecular-weight heparin (Fragmin) in hip fracture surgery. A placebo-controlled study. Clin Orthop Relat Res. 1992;278:95–100.

    PubMed  Google Scholar 

  7. Eriksson BI, Bauer KA, Lassen MR, Turpie AG. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med. 2001;345(18):1298–304.

    Article  CAS  PubMed  Google Scholar 

  8. Nagase Y, Yasunaga H, Hiromasa H, Horiguchi H, Shoda N, Kadono Y, Matsuda S, Nakamura K, Tanaka S. Risk factors for pulmonary embolism and the effects of fondaparinux after total hip and knee arthroplasty: a retrospective observational study with use of a national database in Japan. J Bone Jt Surg Am. 2011;93(24):e146.

    Article  Google Scholar 

  9. Kitamukai O, Sakuma M, Takahashi T, Kagaya Y, Watanabe J, Shirato K. Incidence and characteristics of pulmonary thromboembolism in Japan 2000. Intern Med. 2003;42(11):1090–4.

    Article  PubMed  Google Scholar 

  10. Schneider D, Lilienfeld DE, Im W. The epidemiology of pulmonary embolism: racial contrasts in incidence and in-hospital case fatality. J Natl Med Assoc. 2006;98(12):1967–72.

    PubMed Central  PubMed  Google Scholar 

  11. Yasunaga H, Hashimoto H, Horiguchi H, Miyata S, Matsuda S. Variation in cancer surgical outcomes associated with physician and nurse staffing: a retrospective observational study using the Japanese Diagnosis Procedure Combination database. BMC Health Serv Res. 2012;28(12):129.

    Article  Google Scholar 

  12. Yasunaga H, Horiguchi H, Kuwabara K, Matsuda S, Fushimi K, Hashimoto H, Ayanian JZ. Outcomes after laparoscopic or open distal gastrectomy for early-stage gastric cancer: a propensity-matched analysis. Ann Surg. 2013;257(4):640–6.

    Article  PubMed  Google Scholar 

  13. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I9–16.

    PubMed  Google Scholar 

  14. Wattanakit K, Cushman M, Stehman BC, Heckbent SR, Folsom AR. Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol. 2008;19(1):135–40.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Piazza G, Goldhaber SZ, Kroll A, Goldberg RJ, Emery C, Spencer FA. Venous thromboembolism in patients with diabetes mellitus. Am J Med. 2012;125(7):709–16.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Kawasaki T, Kambayashi J, Sakon M. Hyperlipidemia: a novel etiologic factor in deep vein thrombosis. Thromb Res. 1995;79(2):147–51.

    Article  CAS  PubMed  Google Scholar 

  17. Rosencher N, Vielpeau C, Emmerich J, Fagnani F, Samama CM, ESCORTE group. Venous thromboembolism and mortality after hip fracture surgery: the ESCORTE study. J Thromb Haemost. 2005;3(9):2006–14.

    Article  CAS  PubMed  Google Scholar 

  18. Pulmonary Embolism Prevention (PEP) Trial Collaborative Group. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: pulmonary embolism prevention (PEP) trial. Lancet. 2000;355(9212):1295–302.

    Article  Google Scholar 

  19. McNamara I, Sharma A, Prerost T, Paker M. Symptomatic venous thromboembolism following a hip fracture. Acta Orthop. 2009;80(6):687–92.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Sasaki S, Miyakoshi N, Matsuura H, Saito H, Nakanishi T, Kudo Y, Fujiya T, Shimada Y. Prospective study on the efficacies of fondaparinux and enoxaparin in preventing venous thromboembolism after hip fracture surgery. J Orthop Sci. 2011;16(1):64–70.

    Article  PubMed  Google Scholar 

  21. Sasaki S, Miyakoshi N, Matsuura H, Saitoh H, Kudoh D, Shimada Y. Prospective randomized controlled trial on the effect of fondaparinux sodium for the prevention of venous thromboembolism after hip fracture surgery. J Orthop Sci. 2009;14:491–6.

    Article  CAS  PubMed  Google Scholar 

  22. Khatod M, Inacio MC, Bini SA, Paxton EW. Pulmonary embolism prophylaxis in more than 30,000 total knee arthroplasty patients: is there a best choice? J Arthroplasty. 2012;27(2):167–72.

  23. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol. 2004;24(6):1015–22.

    Article  CAS  PubMed  Google Scholar 

  24. Arcelus JI, Monreal M, Caprini JA, Guisado JG, Soto MJ, Núñez MJ, Alvárez JC, RIETE investigators. Clinical presentation and time-course of postoperative venous thromboembolism: results from the RIETE registry. Thromb Haemost. 2008;99(3):546–51.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was funded by grants from the Ministry of Health, Labour and Welfare, Japan (Research on Policy Planning and Evaluation grant number H22-Policy-031; Research on Intractable Diseases grant number H23-Nanchi-032); the Ministry of Education, Culture, Sports, Science and Technology, Japan (Scientific Research B, No. 22390131); and the Council for Science and Technology Policy, Japan (Funding Program for World-Leading Innovative R&D on Science and Technology FIRST program grant number 0301002001001).

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yusuke Tsuda.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tsuda, Y., Yasunaga, H., Horiguchi, H. et al. Effects of fondaparinux on pulmonary embolism following hemiarthroplasty for femoral neck fracture: a retrospective observational study using the Japanese Diagnosis Procedure Combination database. J Orthop Sci 19, 991–996 (2014). https://doi.org/10.1007/s00776-014-0607-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00776-014-0607-2

Keywords

Navigation